Nanobiotix S.A. (0QAV.L)

EUR 3.48

(1.75%)

Total Assets Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual total assets in 2023 was 93.89 Million EUR , up 57.1% from previous year.
Nanobiotix S.A.'s latest quarterly total assets in 2024 Q2 was 86.68 Million EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported annual total assets of 59.76 Million EUR in 2022, down -41.21% from previous year.
Nanobiotix S.A. reported annual total assets of 101.67 Million EUR in 2021, down -24.08% from previous year.
Nanobiotix S.A. reported quarterly total assets of 93.89 Million EUR for 2023 FY, up 57.1% from previous quarter.
Nanobiotix S.A. reported quarterly total assets of 93.89 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Total Assets of Nanobiotix S.A. (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	93.89 Million EUR	57.1%
2022	59.76 Million EUR	-41.21%
2021	101.67 Million EUR	-24.08%
2020	133.92 Million EUR	138.84%
2019	56.07 Million EUR	21.85%
2018	46.01 Million EUR	-19.54%
2017	57.19 Million EUR	89.63%
2016	30.16 Million EUR	15.12%
2015	26.2 Million EUR	-29.29%
2014	37.05 Million EUR	398.12%
2013	7.43 Million EUR	-46.96%
2012	14.02 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	86.68 Million EUR	0.0%
2023 FY	93.89 Million EUR	57.1%
2023 Q4	93.89 Million EUR	0.0%
2023 Q2	40.4 Million EUR	0.0%
2022 Q4	59.76 Million EUR	0.0%
2022 Q2	80.56 Million EUR	0.0%
2022 FY	59.76 Million EUR	-41.21%
2021 FY	101.67 Million EUR	-24.08%
2021 Q4	101.67 Million EUR	0.0%
2021 Q2	123.82 Million EUR	0.0%
2020 Q2	44.7 Million EUR	0.0%
2020 FY	133.92 Million EUR	138.84%
2020 Q4	133.92 Million EUR	0.0%
2019 Q4	56.07 Million EUR	0.0%
2019 FY	56.07 Million EUR	21.85%
2019 Q2	75.12 Million EUR	0.0%
2018 FY	46.01 Million EUR	-19.54%
2018 Q4	46.19 Million EUR	0.0%
2018 Q2	43.87 Million EUR	0.0%
2017 FY	57.19 Million EUR	89.63%
2017 Q4	57.46 Million EUR	0.0%
2017 Q2	42.38 Million EUR	0.0%
2016 Q2	37.04 Million EUR	0.0%
2016 FY	30.16 Million EUR	15.12%
2016 Q4	30.4 Million EUR	0.0%
2015 Q4	26.41 Million EUR	0.0%
2015 Q2	32.71 Million EUR	0.0%
2015 FY	26.2 Million EUR	-29.29%
2014 FY	37.05 Million EUR	398.12%
2014 Q4	37.05 Million EUR	0.0%
2014 Q2	30.26 Million EUR	0.0%
2013 FY	7.43 Million EUR	-46.96%
2013 Q4	7.43 Million EUR	0.0%
2013 Q2	10.23 Million EUR	0.0%
2012 Q4	14.02 Million EUR	0.0%
2012 Q3	14.02 Million EUR	0.0%
2012 FY	14.02 Million EUR	0.0%

Peer Total Assets Comparison of Nanobiotix S.A.

Name	Total Assets	Total Assets Difference
Boiron SA	590.2 Million EUR	84.091%
Laboratorios Farmaceuticos Rovi, S.A.	799.88 Million EUR	88.261%
Vetoquinol SA	692.23 Million EUR	86.436%
Valneva SE	469.39 Million EUR	79.996%
AB Science S.A.	25.49 Million EUR	-268.238%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	-83.01%
Vivoryon Therapeutics N.V.	30.82 Million EUR	-204.574%
BioSenic S.A.	9.55 Million EUR	-882.289%
ABIVAX Société Anonyme	327.06 Million EUR	71.291%
Formycon AG	890.36 Million EUR	89.454%